Mounting evidence from large-scale association studies has identified transmembrane BAX inhibitor motif-containing 1 (<i>TMBIM1</i>) as a promising candidate gene in colorectal cancer (CRC) pathogenesis. This evidence concerns the gene TMBIM1 and colorectal carcinoma.